Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: Stocks mixed after Russia gas delivery halt

27th Apr 2022 17:00

(Alliance News) - Stocks in London ended mixed on Wednesday as sentiment was stifled after Russia announced it would cease gas exports to Bulgaria and Poland, while heavyweight miners kept the FTSE 100's head above water. Read More

UK shareholder meetings calendar - next 7 days

27th Apr 2022 16:03

TOP NEWS SUMMARY: Microsoft shares up, Alphabet down after results

27th Apr 2022 10:50

(Alliance News) - The following is a summary of top news stories Wednesday. Read More

TOP NEWS: Glaxo posts quarterly profit rise; on track demerging Haleon

27th Apr 2022 10:06

(Alliance News) - GlaxoSmithKline PLC on Wednesday reported a higher quarterly profit as it announced it is on track to demerge and list its consumer healthcare arm Haleon. Read More

LONDON MARKET PRE-OPEN: Lloyds and WPP raise outlook; Aveva cautions

27th Apr 2022 07:53

(Alliance News) - Stock prices in London are set to open higher on Wednesday, despite the brutal losses endured in New York overnight, though with sentiment downbeat following mixed US tech earnings and concerns over an escalation of tensions between Russia and the EU. Read More

LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley

22nd Apr 2022 09:21

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon: Read More

UK earnings, trading statements calendar - next 7 days

20th Apr 2022 16:07

Drugmaker GlaxoSmithKline faces strike over "derisory" pay offer

20th Apr 2022 14:20

(Alliance News) - Hundreds of UK workers at pharmaceutical giant GlaxoSmithKline PLC are set to strike over a "derisory" pay offer way below the level of British inflation, a union said Wednesday. Read More

GlaxoSmithKline says FDA accepts application for kidney disease drug

19th Apr 2022 08:36

(Alliance News) - GlaxoSmithKline PLC on Tuesday said the US Food & Drug Administration has accepted the company's application for the review of kidney disease drug daprodustat. Read More

LONDON BROKER RATINGS: BofA raises Rightmove; Berenberg cuts Bunzl

14th Apr 2022 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday afternoon: Read More

TRADING UPDATES: Sureserve gets new CFO; Sareum notes GSK buys Sierra

13th Apr 2022 21:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

LONDON MARKET MIDDAY: Miners keep FTSE 100 afloat after hot inflation

13th Apr 2022 12:02

(Alliance News) - The FTSE 100 was treading water around midday on Wednesday, following the third straight extraordinary inflation print of the week. Read More

TOP NEWS: GlaxoSmithKline to buy Sierra Oncology for USD1.9 billion

13th Apr 2022 09:34

(Alliance News) - GlaxoSmithKline PLC on Wednesday said it reached an agreement to acquire late-stage biopharmaceutical company Sierra Oncology Inc for USD1.9 billion, or GBP1.5 billion. Read More

LONDON MARKET PRE-OPEN: UK inflation rips to 30-year high; GSK buys

13th Apr 2022 07:51

(Alliance News) - Stocks in London were called flat on Wednesday morning as investors digest surging UK inflation data, which follows on the heels of red-hot consumer prices in the US and Germany. Read More

LONDON BROKER RATINGS: Jefferies raises John Wood; Investec cuts Metro

11th Apr 2022 09:55

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

LONDON BROKER RATINGS: Barclays downgrades Lloyds and Virgin Money

5th Apr 2022 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

UK dividends calendar - next 7 days

31st Mar 2022 15:11

GSK, CureVac begin development of second generation Covid-19 vaccine

30th Mar 2022 12:15

(Alliance News) - GlaxoSmithKline PLC said on Wednesday it started the clinical development of its second-generation Covid-19 vaccine candidate, CV2CoV, along with German biopharmaceutical company CureVac NV. Read More

J&J's Cabenuva HIV treatment approved in US for adolescents

30th Mar 2022 08:57

(Alliance News) Johnson & Johnson said on Tuesday its HIV drug collaboration, Cabenuva, has received further approvals in the US. Read More

REPEAT: US FDA revises use for GSK's Covid-19 neutralizing antibody

25th Mar 2022 20:56

(Alliance News) - GlaxoSmithKline PLC said on Friday that the US Food & Drug Administration has amended the emergency use authorization fact sheet for sotrovimab, an investigational Covid-19 neutralizing monoclonal antibody. Read More

FTSE 100 Latest

Value8,774.65

Change-17.15